ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Abstract 1743: Phase 1 clinical trial of the base-excision repair inhibitor Methoxyamine-HCl (TRC102; MX) in combination with Temozolomide (TMZ) in patients with solid tumors
Mapping Intimacies
◽
10.1158/1538-7445.am2012-1743
◽
2012
◽
Cited By ~ 1
Author(s):
Panos S. Savvides
◽
Yan Xu
◽
Lili Liu
◽
Lisa Rogers
◽
Joseph Bokar
◽
...
Keyword(s):
Clinical Trial
◽
Solid Tumors
◽
Base Excision Repair
◽
Excision Repair
◽
Phase 1
◽
Phase 1 Clinical Trial
◽
Base Excision
Download Full-text
Related Documents
Cited By
References
Abstract 753: Pharmacokinetic profile of the base-excision repair inhibitor methoxyamine-HCl (TRC102; MX) given as an one-hour intravenous infusion with temozolomide (TMZ) in the first in human phase 1 clinical trial
10.1158/1538-7445.am2012-753
◽
2012
◽
Cited By ~ 1
Author(s):
Panos S. Savvides
◽
Yan Xu
◽
Lili Liu
◽
Lisa Rogers
◽
Smitha Krishnamurthi
◽
...
Keyword(s):
Clinical Trial
◽
Base Excision Repair
◽
Intravenous Infusion
◽
Excision Repair
◽
Phase 1
◽
Pharmacokinetic Profile
◽
Phase 1 Clinical Trial
◽
Base Excision
Download Full-text
A phase 1 study of TRC102, an inhibitor of base excision repair, and pemetrexed in patients with advanced solid tumors
Investigational New Drugs
◽
10.1007/s10637-012-9876-9
◽
2012
◽
Vol 31
(3)
◽
pp. 714-723
◽
Cited By ~ 18
Author(s):
Michael S. Gordon
◽
Lee S. Rosen
◽
David Mendelson
◽
Ramesh K. Ramanathan
◽
Jonathan Goldman
◽
...
Keyword(s):
Solid Tumors
◽
Base Excision Repair
◽
Excision Repair
◽
Phase 1
◽
Advanced Solid Tumors
◽
Phase 1 Study
◽
Base Excision
Download Full-text
Phase I clinical trial of temozolomide and methoxyamine (TRC-102), an inhibitor of base excision repair, in patients with advanced solid tumors
Investigational New Drugs
◽
10.1007/s10637-020-00962-x
◽
2020
◽
Cited By ~ 1
Author(s):
Jennifer R. Eads
◽
Smitha S. Krishnamurthi
◽
Joel Saltzman
◽
Joseph A. Bokar
◽
Panos Savvides
◽
...
Keyword(s):
Clinical Trial
◽
Phase I
◽
Solid Tumors
◽
Base Excision Repair
◽
Excision Repair
◽
Phase I Clinical Trial
◽
Advanced Solid Tumors
◽
Base Excision
Download Full-text
Abstract B62: A phase 1 study of oral TRC102 (methoxyamine), an inhibitor of base‐excision repair, to potentiate the therapeutic effects of pemetrexed in patients with advanced refractory cancer
10.1158/1535-7163.targ-09-b62
◽
2009
◽
Author(s):
Michael S. Gordon
◽
Glen J. Weiss
◽
Lee S. Rosen
◽
David S. Mendelson
◽
Ramesh K. Ramanathan
◽
...
Keyword(s):
Base Excision Repair
◽
Excision Repair
◽
Phase 1
◽
Therapeutic Effects
◽
Phase 1 Study
◽
Base Excision
Download Full-text
Final Report on Phase 1 Clinical Trial of Oral Pparгagonist Efatutazone (CS-7017) in Japanese Patients with Metastatic Solid Tumors
Annals of Oncology
◽
10.1016/s0923-7534(20)32297-3
◽
2012
◽
Vol 23
◽
pp. xi110-xi111
Author(s):
Y. Onozawa
◽
H. Murakami
◽
A. Ono
◽
T. Tushima
◽
T. Takahashi
◽
...
Keyword(s):
Clinical Trial
◽
Solid Tumors
◽
Phase 1
◽
Japanese Patients
◽
Final Report
◽
Phase 1 Clinical Trial
Download Full-text
Phase I clinical trial of the base excision repair inhibitor methoxyamine in combination with fludarabine for patients with advanced hematologic malignancies
Oncotarget
◽
10.18632/oncotarget.20094
◽
2017
◽
Vol 8
(45)
◽
pp. 79864-79875
◽
Cited By ~ 7
Author(s):
Paolo F. Caimi
◽
Brenda W. Cooper
◽
Basem M. William
◽
Afshin Dowlati
◽
Paul M. Barr
◽
...
Keyword(s):
Clinical Trial
◽
Phase I
◽
Base Excision Repair
◽
Excision Repair
◽
Hematologic Malignancies
◽
Phase I Clinical Trial
◽
Base Excision
Download Full-text
Pharmacokinetic profile of the base-excision repair inhibitor methoxyamine-HCl (TRC102; MX) given as an one-hour intravenous infusion with temozolomide (TMZ) in the first-in-human phase I clinical trial.
Journal of Clinical Oncology
◽
10.1200/jco.2010.28.15_suppl.e13662
◽
2010
◽
Vol 28
(15_suppl)
◽
pp. e13662-e13662
Author(s):
P. Sawides
◽
Y. Xu
◽
L. Liu
◽
J. A. Bokar
◽
P. Silverman
◽
...
Keyword(s):
Clinical Trial
◽
Phase I
◽
Base Excision Repair
◽
Intravenous Infusion
◽
Excision Repair
◽
Pharmacokinetic Profile
◽
Phase I Clinical Trial
◽
Base Excision
Download Full-text
A phase 1 clinical trial of sequential pralatrexate followed by a 48-hour infusion of 5-fluorouracil given every other week in adult patients with solid tumors
Cancer
◽
10.1002/cncr.29504
◽
2015
◽
Vol 121
(21)
◽
pp. 3862-3868
◽
Cited By ~ 1
Author(s):
Jean L. Grem
◽
Mary E. Kos
◽
Ruby E. Evande
◽
Jane L. Meza
◽
James K. Schwarz
Keyword(s):
Clinical Trial
◽
Solid Tumors
◽
Phase 1
◽
Adult Patients
◽
Phase 1 Clinical Trial
Download Full-text
Modulation of Base Excision Repair Alters Cellular Sensitivity to UVA1 but not to UVB¶
Photochemistry and Photobiology
◽
10.1562/0031-8655(2002)075<0507:mobera>2.0.co;2
◽
2002
◽
Vol 75
(5)
◽
pp. 507
◽
Cited By ~ 13
Author(s):
Katherine J. Kim
◽
Indraneel Chakrabarty
◽
Guang-Zhi Li
◽
Sabine Grösch
◽
Bernd Kaina
◽
...
Keyword(s):
Base Excision Repair
◽
Excision Repair
◽
Cellular Sensitivity
◽
Base Excision
Download Full-text
Defective Base Excision Repair Associated with NTHL1
Reactome - a curated knowledgebase of biological pathways
◽
10.3180/r-hsa-9616333.1
◽
2019
◽
Vol 68
◽
Author(s):
Richarda de Voer
◽
Paul W Doetsch
◽
Roland Kuiper
◽
Barbara Rivera
Keyword(s):
Base Excision Repair
◽
Excision Repair
◽
Base Excision
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close